Table 3:

Patient demographics and operative procedure information (CND, central neck dissection; MLND, modified lateral neck dissection).

Total cases using PTeye™	19 (initial set)	64 (2nd set)	83 (overall)
Age (years, range)	57 (20 – 75)	52 (22 – 83)	54 (20 – 83)
Gender
Male	5 (26.3%)	18 (28.1%)	23 (27.7%)
Female	14 (73.7%)	46 (71.9%)	60 (72.3%)
Body Mass Index (kg/m2, range)	28 (22 – 39)	30 (17 – 54)	29 (17 – 54)
Race
Caucasian	16 (84.2%)	55 (85.5%)	71 (85.5%)
Non-Caucasian	2 (10.5%)	9 (13.3%)	11 (13.3%)
Unknown	1 (5.3%)	0 (1.2%)	1 (1.2%)
Ethnicity
Hispanic	0 (0%)	2 (3.1%)	2 (2.4%)
Non-Hispanic	17 (89.5%)	62 (96.9%)	79 (95.2%)
Unknown	2 (10.5%)	0 (0%)	2 (2.4%)
Operative procedure
Thyroidectomy	9 (47.4%)	28 (43.8%)	37 (45.6%)
Parathyroidectomy	10 (52.6%)	36 (56.2%)	46 (55.4%)
Parathyroid specific data
Procedure
Focused	1 (10%)	8 (22.2%)	9 (19.6%)
Bilateral neck exploration	9 (90%)	28 (77.8%)	37 (80.4%)
Re-operative surgery
Yes	4 (40%)	3 (8.3%)	7 (15.2%)
No	6 (60%)	33 (91.7%)	39 (84.8%)
Diagnosis
Primary hyperparathyroidism	10 (100%)	34 (94.4%)	44 (95.7%)
Tertiary hyperparathyroidism	0 (0%)	2 (5.6%)	2 (4.3%)
Thyroid specific data
Procedure
Thyroid lobectomy	4 (44.5%)	4 (14.2%)	8 (21.6%)
Total thyroidectomy	3 (33.3%)	19 (67.9%)	22 (59.5%)
Total thyroidectomy with CND	1 (11.1%)	1 (3.6%)	2 (5.4%)
Total thyroidectomy with CND and MLND	1 (11.1%)	2 (7.1%)	3 (8.1%)
Completion thyroidectomy	0 (0%)	1 (3.6%)	1 (2.7%)
Prophylactic thyroidectomy	0 (0%)	1 (3.6%)	1 (2.7%)
Diagnosis
Multinodular goiter/thyroid nodule	1 (11.1%)	13 (46.4%)	14 (37.8%)
Hyperthyroidism (Graves/toxic nodule)	5 (55.6%)	10 (35.7%)	15 (40.6%)
Well-differentiated thyroid cancer	3 (33.3%)	3 (10.7%)	6 (16.2%)
Recurrent/residual thyroid disease	0 (0%)	1 (3.6%)	1 (2.7)
Multiple Endocrine Neoplasia, Type IIA*	0 (0%)	1 (3.6%)	1 (2.7)

^*Asymptomatic patient underwent prophylactic thyroidectomy

Age, body mass index reported as median, all others n (%)